Objective: Physical activity (PA) is essential for successful aging and for the prevention and management of common chronic diseases. The empirical support for the beneficial effects of PA on vasomotor symptoms has, however, been mixed. The purpose of this study was to assess the effects of acute aerobic exercise and daily PA on menopausal vasomotor symptoms.
R egular physical activity (PA) has numerous health benefits, many of which are directly relevant to postmenopausal women such as reduction in the risk for cardiovascular disease, diabetes, osteopenia and osteoporosis, some cancers, and depression. 1 One area in which support for the beneficial influence of PA remains unconvincing is its effect on vasomotor symptoms. Vasomotor symptoms affect most American women as they transition through menopause, and for some, these symptoms become severe enough to negatively impact daily functioning and quality of life. 2<5 Disheartening for many women is also the finding that vasomotor symptoms last much longer than previously thought (95-8 y on average), with 10% of women experiencing these symptoms as long as 12 years postmenopause. 6, 7 Most women are reluctant to treat their symptoms with pharmacological approaches and opt instead for more natural methods that may include behavior modification through PA.
Reviews of research examining the effects of exercise and other forms of PA on vasomotor symptoms attest to the growing interest in pursuing PA as a modality for symptom management. 8<11 The overall conclusion nonetheless remains that there is insufficient evidence that PA alleviates vasomotor symptoms. Moreover, one study documented an increase in self-reported vasomotor symptoms in some women as part of a year-long exercise intervention trial. 12 In another laboratorybased study, objectively measured vasomotor symptoms increased within 24 hours after a moderate-intensity exercise bout. 13 Perceived physical exertion also preceded hot flashes (HFs) in a study involving 2 days of ambulatory HF monitoring in a real-life setting. 14 HFs are believed to serve a heat dissipating function. Specifically, the thermoregulatory model posits that HFs are caused by altered neurotransmitter release in the hypothalamus, disrupting the regulation of the thermoregulatory center such that the core body temperature threshold for sweating is lowered, reducing the thermoneutral zone (ie, sweating occurs at lower body core temperature). 15, 16 PA increases body core temperature and might thus stimulate more HFs, especially when performed at high exercise intensities or for long durations. On the other hand, a protective role of PA in alleviating HFs may be expected given its other neuroendocrine, 17<19 body composition, thermoregulation, fitness, and psychological effects. 20<22 There are no sufficiently powered randomized controlled trials of aerobic exercise targeting HFs as the primary outcome. 11 The remaining studies are limited by the absence of both subjective and objective measures of PA and menopausal HFs. Consequently, it is unclear whether acute or chronic PA impacts primarily processes involved in symptom perception and reporting or whether any of the aforementioned physiological mechanisms are at play and having any discernible impact on objectively measured HFs. Therefore, the present study had two main purposes. First, we sought to evaluate whether an acute bout of moderate-intensity aerobic exercise increases subjective and objective vasomotor symptoms, as previously reported by Freedman and Krell. 13 Second, we examined whether objectively measured PA is associated with subjective HFs across a 2-week monitoring period Bin a real life setting[ during which HFs were self-reported on a personal digital assistant (PDA). At the same time, we evaluated whether there are individual differences in the responses to acute exercise and daily PA associated with characteristics (cardiorespiratory fitness, weight status, or menopause status) likely to influence the relation between PA and HFs. 9,23<25
METHODS Participants
Community-dwelling midlife women (N = 121; age range, 40-60 years) not using hormone therapy for at least 6 months were recruited for a prospective daily diary study on PA and psychological function, which included an experimental acute exercise bout. The study was advertised as a study of psychological and physiological effects of exercise in middleaged women in a variety of community-based settings such as public bulletin boards, libraries, and physician's offices and through online listserves. Ninety-two women from this sample reported menopause-related vasomotor symptoms (night sweats or HFs) within the last 2 weeks, and their data were used in the analysis for this study.
Study design
As part of screening into the study, all women completed cardiorespiratory fitness (maximal graded exercise test using TrueMax2400 metabolic system; Parvomedics Inc., Salt Lake City, UT), body composition (dual-energy x-ray absorptiometry), menopausal (self-reported menstrual bleeding history), and hormonal status (blood draw) screening. All women also completed a baseline battery of psychological questionnaires, three laboratory sessions, and prospective monitoring across a 15-day period. All symptomatic women additionally completed two 24-hour Biolog (model 3991/1-SCL; UFI, Morro Bay, CA) sternal skin conductance recordings of HFs, one at baseline (day 1) and one immediately after the acute exercise bout, which occurred during their second laboratory visit, usually between days 5 and 8 of the 15-day study. PA was monitored objectively with an activity monitor that used a uniaxial accelerometer (model GT1M; ActiGraph, Pensacola, FL), and daily HF symptoms were self-reported in real-time using the PDA (Tungsten E2) device.
Laboratory session 1 was scheduled on the first day of the study (usually in the morning) and consisted of a familiarization procedure to the study protocol and a tutorial on PDA and activity monitor use. All symptomatic women were subsequently fitted with a Biolog sternal skin conductance monitor, which they were asked to wear for a 24-hour period. The first laboratory session was followed by a 15-day prospective assessment of PA and vasomotor symptoms.
During week 1 of this prospective monitoring, women attended their second laboratory visit, during which they completed a 30-minute moderate-intensity exercise bout. This exercise bout was performed (in the morning or early afternoon) on a treadmill at a self-selected pace and consisted of a 5 minute warm-up, 20 minute steady state exercise, and a 5minute cool-down period. Women were instructed to selfselect a pace corresponding to ratings of perceived exertion between 12 (light/somewhat hard) and 15 (somewhat hard/ hard) on the Borg Ratings of Perceived Exertion scale. 26 The moderate intensity was corroborated objectively through intermittent assessment of oxygen uptake during exercise and corresponded, on average, to 60% of peak oxygen uptake determined during screening, a level considered moderate based on the guidelines of the American College of Sports Medicine. 27 After the exercise bout, all symptomatic women were again fitted with the skin conductance monitor for another 24-hour ambulatory HF monitoring session.
Measures

Background information
Basic demographic and health history information included menopause status based on self-reported bleeding patterns and categorized according to the Stages of Reproductive Aging Workshop criteria. 28 During initial telephone screening, the women were asked about their menstrual bleeding patterns and subsequently completed a questionnaire that presented several yes/no statements (eg, I have had normal menses during the last 12 months) corresponding to the Stages of Reproductive Aging Workshop menopausal categories.
Physical activity
Habitual PA was assessed objectively through continuous monitoring with the accelerometer, which was positioned over the participants' nondominant hip with an adjustable elastic belt. Participants wore the accelerometer for the entire data collection period (ie, 15 days) and were asked to take off the accelerometer when in contact with water (eg, bathing or swimming). The accelerometer collected data in 1 minute epochs, and the data were processed and analyzed using the ActiLife data analysis software from ActiGraph (version 5.7.4). Wear-time was validated through the ActiLife software procedures, with valid hour considered to have at least 10% of nonzero activity counts and valid day reflecting at least 10 valid hours. Only valid data were analyzed. The primary PA measures in this study were total daily PA counts, percentage time of daily activity spent sedentary (0-100 cpm) or engaged in lifestyle (101-759 cpm), light (760-1,952 cpm), moderate (1,953-5,724 cpm), and vigorous (5,725+ cpm) PAs. The selected cutpoints are based on criteria previously established by Freedson et al. 29 One of the 92 women lost her activity monitor; thus, data from only 91 participants were used in the analysis involving daily PA. In addition to PA, body mass index (BMI) was computed from weight and height measured in the laboratory using standardized procedures.
Hot flashes
The Purdue Momentary Assessment platform was used to collect the data on HF symptoms self-reported in real-time on the PDA. 30 Women entered each HF as a separate event (timestamped automatically by the PDA) and, each time, answered questions regarding how long ago the HF occurred, its duration, severity, and some relevant contextual information regarding location, approximate temperature, type of activity performed at the moment of the HF, and previous intake of HF-triggering types of foods and beverages. The data were downloaded on to a computer and processed to determine the total number of reported unique HF events per day.
Objective HFs were determined from continuous skin conductance monitoring using the Biolog HF monitor, a batterypowered, portable device (14 Â 7 Â 3 cm) that measures skin conductance through two electrodes (1.5 cm in diameter) attached to the sternum. In addition to continuous monitoring, participants are also instructed to press two event mark buttons simultaneously when they perceived a HF, providing timestamped self-reported HF data. HFs entered through event marks were compared with PDA entries and counted as the same event if within 5 minutes of each other. Skin conductance data were processed using the FlashTrax software (version 1.2e; UFI, Morro Bay, CA). Standard criteria were used to detect HFs using the FlashTrax auto analysis features. Increases in skin conductance of 2 Kmho or higher in a 30second period were electronically marked and considered as potential HFs. Two trained research assistants then independently visually inspected the data to verify the events and distinguish them from noise or artifact. Both sets of analyses were then compared, and differences were reconciled by mutual agreement among the assistants and the principal investigator. Periods of noisy data that were deemed noninterpretable were excluded from the data, and the daily totals were adjusted for valid wear time. For descriptive purposes, the data are reported as rates representing the number of HF events per valid hour of recording on each monitoring day. The rate of true-positive, false-negative, and false-positive HFs was established by comparing subjective HF reports (either on PDA or through Biolog event marks) with objective HFs (Biolog skin conductance). A physiologically objective event that was accompanied by a subjective report within 5 minutes was considered a true-positive HF. An objective event not accompanied by a subjective report within 5 minutes was considered a false-negative HF, and a subjective report without an objective event within 5 minutes was considered a false-positive HF. 14, 31 HF events detected or reported between 11:00 PM and 6:00 AM were considered night sweats. Because women were not required to self-report these events while asleep, analysis was performed without these events in the daily rates at first. For objective HFs, we then repeated the analysis with these nighttime events (ie, presumptive night sweats). Ultimately, complete before and after data for both objective and subjective symptoms were available for 84 of the 92 symptomatic women. The main reasons for the missing data were technical problems with the Biolog monitors. A series mean imputation method was used to replace the missing values. Where results differed as a function of this imputation, the findings were noted for both sets of analyses (ie, with imputed missing values vs with missing cases present).
Statistical analysis Acute exercise effects
Descriptive statistics were used to describe the sample, and a set of generalized estimating equation (GEE) analyses 32 were conducted to determine whether there were changes on the sets of HF variables from pre-exercise to postexercise and to determine whether there was a time (pre-exercise to postexercise) Â grouping variable (ie, fitness, weight and menopausal and overall symptom burden status) interaction on the HF variables. The GEE method was used because (1) the dependent variables (ie, HF variables) were count data (violating the assumption of normal distribution); (2) GEE has the option to analyze count data with a log link function, thus providing more accurate results than other conventional statistical methods that may underestimate standard errors; (3) GEE is the more appropriate method to use for the analysis of correlated data (participants' pre-exercise HFs were moderately correlated with their postexercise HFs in this study). 32 The GEE analyses were performed separately for total objective and subjective HFs and for true-positive, false-negative, and false-positive HFs. For total objective HFs, the analysis was repeated including both daytime HFs and night sweats. Total hours of valid wear time was used as an offset variable in the GEE analyses to adjust for differences in valid HF recording hours. To evaluate differences in response based on fitness, weight and menopausal and overall symptom burden status, women were categorized into high (higher fit women; 950th percentile age-matched) and low (lower fit women; e50th percentile age-matched) fitness categories based on peak oxygen uptake achieved during the graded exercise test at screening. 27 BMI was used to categorize women into normal (BMI, G25) and overweight/obese (BMI, Q25) categories. Menopause status reflected three categoriesVearly perimenopausal, late perimenopausal, and postmenopausal. 28 To examine whether the acute bout had a differential effect on symptoms depending on overall symptom burden, we categorized women into tertiles based on the average frequency of symptoms reported across the entire 15-day monitoring period. The analyses were performed using SPSS 19.0 statistical software package.
Daily PA effects
Daily PA and HF reports were nested within people; thus, multilevel modeling was used to test the association between daily PA and self-reported HFs. This approach allows for examining both between-and within-person associations between PA and HFs. 33 To separately test betweenand within-person associations, daily PA measures and HFs were person centered. 34<36 For example, person 1's overall level of PA was calculated as the within-person mean of her PA counts across the 15-day study period and each person's daily PA was calculated as the deviation of day d's score from the individual mean. Therefore, this score represents PA fluctuations from individual mean, equivalent to being more or less active that day than on usual days. Separate models were run for total PA (daily activity counts), lifestyle PA, lightintensity PA, moderate-intensity PA, vigorous-intensity PA, and sedentary time as the independent (exposure) variables. SAS 9.2 PROC MIXED 36 was used to test the following multilevel model by regressing daily HF on overall and daily PA:
Within<Person Model ðLevel 1Þ:
Between<Person Model ðLevel 2Þ:
where F 00 represents the average level of HFs in the sample, F 01 represents the influence of PA and HFs (ie, between-person effect), F 10 represents the average effect of PA fluctuations (ie, average within-person effects) on HFs, and u 0i are individuallevel residual deviations that are uncorrelated with the day-level residuals e di . Of particular interest for our research questions are the F 01 and F 10 parameters quantifying the between-person and within-person associations between PA and HFs.
RESULTS
Sample description
Descriptive statistics for the 92 symptomatic women are presented in Table 1 . Participants were, on average, 52 years old and predominantly non-Hispanic white. Most were married or in committed relationships, were well educated, had income above $65,000 (68%), and had at least one child. There was a representation across different menopause stages. During a 24-hour baseline assessment, women self-reported a total of 
Acute exercise effects on hot flashes
When analyzing daytime HFs only, the analysis indicated that both total objective and total subjective HFs decreased after the acute exercise bout, but the change was statistically significant only for subjective HFs (A = j0.257, P = 0.054 for objective, and A = j0.305, P = 0.010 for subjective HFs; Fig. 1 ). On average, objective daytime HF count after exercise (POST) was about 77% of the count before exercise (PRE) . For subjective HFs, the POST count was about 74% of the PRE count. When analyzing acute exercise effects on symptoms expressed as counts of true-positive, false-negative, and false-positive symptoms, there was a significant reduction in true positive HFs from PRE to POST exercise (A = j0.53, P = 0.008). On average, true-positive daytime HF count after exercise (POST) was about 59% of the PRE count before exercise. There was no significant difference between PRE and POST false-negative HFs (P = 0.231) or false-positive HFs (P = 0.923; Fig. 2 ). When both daytime HFs and night sweats were included, there was a significant reduction in total objective vasomotor symptoms (both HFs and night sweats): A = j0.241, P = 0.028. On average, the POST objective vasomotor symptom count was about 78.6% of the PRE count. Reflecting objective night sweats only, there was no significant change from before to after exercise.
When evaluating variation in symptom responses by fitness, weight, menopausal, and overall symptom burden status, respectively, there were no statistically significant time Â group interactions for any of the HF variables when analyzing the data with imputed missing values. In the analysis of data with missing values (G10% missing), significant differences by menopausal and weight status were observed on selected HF variables. Specifically, with control for any other grouping variables, significant weight status by time interaction on false-positive daytime HF count was observed (P = 0.039). Normal-weight women were more likely to report less falsepositive HF count after exercise, whereas overweight women reported slightly more false-positive HFs after exercise. There was also a significant menopause status Â time interaction on false-positive daytime HF count (P = 0.020), with late perimenopausal women reporting significantly more false-positive HFs after exercise compared with before exercise, whereas early postmenopausal and late postmenopausal women reported similar rates of false-positive HFs after exercise compared with before exercise. Finally, with control for any other grouping variables, significant weight status Â time interaction on total subjective daytime HF count was revealed (P = 0.046). Normal-weight women had greater reduction in subjective HFs after exercise as compared with overweight women. It must be noted that the aforementioned interaction effects were only present when all other grouping variables were included in the model. For descriptive purposes, rates of HFs per valid wear time hour by all grouping categories are presented in Table 2 .
Effects of daily PA on self-reported HFs
The longitudinal multilevel analysis revealed substantial variation in both daily PA and HFs at the between-and within-person levels, respectively. The intraclass correlation cofficients reflecting between-person variation were 41% and 42% for PA and HFs, respectively, suggesting that 59% of the PA and 58% of the HF data varied within persons over time. There were no statistically significant associations between daily HFs and overall PA or in categories of PA (sedentary time, lifestyle PA, light-intensity PA, or vigorous-intensity PA) at either the between-or within-person level. At the between-person level, there was no relationship between a woman's overall level of moderate-intensity activity and HF frequency (t 73 = j1.22, P = 0.22). At the within-person level, however, a woman's daily fluctuations in moderate-intensity activity covaried significantly with self-reported HF frequency (t 949 = 2.98, P G 0.01). That is, on days when a woman was more active than usual, she also reported more HFs. Daily within-person fluctuations in HFs did not differ from women with a different overall activity level (t 949 = j1.53, P = 0.13). Put differently, reporting more or less HFs on a given day did not depend on how active a woman was overall ( Table 3) .
We also evaluated the influence of fitness and BMI as additional between-person factors in the same multilevel model. The within-person association between daily HFs and fluctuations in moderate-intensity PA varied significantly by fitness level (t 942 = j2.20, P G 0.05), revealing that this positive within-person association between daily HFs and moderate PA could be explained by differences in fitness such that lower fit women tended to self-report more HFs with an increasing amount of moderate PA ( Table 4 ). The interaction terms with BMI and menopause status were not statistically significant, suggesting that differences in weight or menopause status did not account for the positive within-person association between self-reported HFs and moderate PA.
DISCUSSION
This study is the first to evaluate the links between PA and menopausal HFs using both objective and subjective measures. A key finding is that an acute bout of moderate-intensity aerobic exercise decreases both objective and subjective HFs. Although overall PA was not associated with HF frequency in longitudinal analyses during a 15-day period, lower fit women reported more vasomotor symptoms on days when they engaged in more moderate-intensity PA than usual. These findings extend our understanding of the relationship between PA and vasomotor symptoms, given the absence of sufficiently powered randomized controlled trials 11 and the lack of studies corroborating self-report assessments with objective measures of both PA and vasomotor symptoms.
Our study demonstrated that an acute bout of exercise reduces both objectively and subjectively measured symptoms. This finding is inconsistent with the suppositions of the thermoregulatory model of HFs, which suggests that more HFs should follow periods of activity that increase body core temperature such as moderate-intensity exercise. The only other study that directly evaluated acute effects of exercise on objectively measured HFs was conducted by Freedman and Krell 13 and noted a triggering of HFs after exercise in a laboratory setting. The most probable explanation for the differing results involves the overall level of HFs in our sample, which was rather low compared with the Freedman and Krell 13 study. Interestingly, the calculated effect sizes in the present study indicate it was the women in the two lowest symptom burden categories that experienced symptom reductions, with women in the highest category showing little change (ds = j0.25, j0.47, and j0.04, for low-, moderate-, and high-symptom burden, respectively). Notably, the average number of HFs reported on the PDA across 15 days in the highest symptom burden category was 2.4 HFs per day, which is about half the symptoms used as a criterion for entry into the Freedman and Krell 13 study (Q5 HFs per day) and is also below the Food and Drug Administration definition of moderate to severe symptoms (7-8 HFs per day). 36 In addition, the Freedman and Krell 13 study differed from our study in target population (postmenopausal women vs perimenopausal and postmenopausal in our study), environment (HF monitoring in controlled laboratory environment vs in real-life setting in our study), mode and duration of exercise (cycle ergometer at 40% predicted oxygen consumption until an HF occurred, 60 min passed, or participants requested termination vs a standard 30-min exercise session on a treadmill in our study). The intensity of exercise was nonetheless comparable between the two studies when expressed as percentage predicted oxygen consumption. Future studies are needed to evaluate potential increases in symptoms after exercise in women who are highly symptomatic. More symptomatic women may be also disproportionately represented by overweight (as opposed to normal weight) and late perimenopausal women, the two groups of women who tended to exhibit smaller reductions in subjective symptoms in our study with controls for each other and the effects of other characteristics (ie, fitness and symptom burden).
Our study also examined the relationship between daily (habitual) PA and self-reported HFs. At the between-person level, there was no association between any of the PA indicators and HFs. However, in within-person analyses, time spent in moderate-intensity activity was positively associated with subjective HFs among lower fit women. The effect of daily PA and HFs did not significantly vary by BMI or menopause status. The involvement of cardiorespiratory fitness in the mechanisms of the association between PA and HFs is plausible given the numerous adaptations endurance-trained persons exhibit in thermoregulatory control as compared with untrained persons. 38 In addition to attenuated blood pressure and heart rate responses to exercise, aerobically trained individuals exhibit blunted sympathetic vasomotor activation compared with untrained individuals. 39 Sympathetic activation is higher in symptomatic compared with asymptomatic postmenopausal women; drugs that increase sympathetic activation provoke HFs, and drugs that decrease this activation ameliorate them. It is believed that an increase in sympathetic activation narrows the thermoneutral zone, which increases the likelihood of HFs, whereas decreased sympathetic activation widens it. 15 In addition, decreases in cardiac vagal control were observed during HFs 40 and aerobically fit/endurance trained individuals have higher heart rate variability (an indirect measure of increased cardiac vagal control) than less fit/ sedentary individuals. 41 Given these effects involving both sympathetic and parasympathetic control, cardiorespiratory fitness may protect women from experiencing HFs in response to chronic PA.
Our analysis regarding the effects of daily PA on HFs evaluated only self-reported symptoms. Unfortunately, most devices that measure HFs objectively do so for short periods of time (24-72 h) or require that sensors be replaced every 24 hours (eg, Biolog), or their validity has not been widely established (eg, FlashMarkPro 42 ). It should also be noted that any objective monitoring technology may be limited for evaluation of vasomotor symptoms during PA. Because most rely on measurements of sweating responses or humidity detection, they are, by design, unsuitable for use during exercise or periods of PA that result in profuse sweating. Selfreport measures thus remain the best option for PA researchers but should be conducted in real time (eg, using electronic diaries) to minimize recall bias. Self-reported HFs have the additional advantage of face validity; they reflect symptoms that matter to women. In fact, just as in other studies, 43 objective and subjective HFs were highly discordant in our study, with a significant number of objective HFs not reported by women or reported by women but not objectively detected. Potential explanations for this discordance may include individual differences in somatosensory sensitivity or affect, 44 but more studies are needed to help disentangle the reasons behind underreporting and to improve the sensitivity of objective measures of HFs. 45 Our sample was well-characterized in terms of health, PA, vasomotor symptoms, and menopause status; however, the women were mostly non-Hispanic white, educated, and of above average socioeconomic status. Future studies should incorporate more ethnically diverse samples to allow for broader generalizability, especially given the ethnic and racial differences in symptom experiences and reporting 46 and in rates of PA. 47 Although this is the first study to evaluate changes in objectively and subjectively measured symptoms as a function of acute exercise, our baseline monitoring session did not immediately precede our acute exercise bout. Given the high variability in symptoms, it would be useful to monitor HFs objectively for longer than 24 hours and as close to an acute exercise bout as possible. It should also be noted that the within-person association between moderate-intensity activity and HFs may be dependent on the operational definition of moderate-intensity activity used. We used previously established criteria 29 ; however, other criteria can be used to classify intensity levels. For example, the criteria established by Matthews 48 specify moderate intensity as an activity level involving accelerometer counts between 760 and 5,724 cpm, a wider range than that proposed by Freedson et al 29 (where 1,953-5,724 cpm was considered as moderate). The within-person association was no longer significant when moderate-intensity PA was defined using the Matthews 48 criteria. Therefore, it is important to interpret our findings as specifically reflecting intensity corresponding to 1,953 to 5,724 accelerometer counts per minute.
CONCLUSIONS
This study demonstrated that an acute bout of moderateintensity exercise decreases both objectively and subjectively assessed HFs but that overweight and late perimenopausal women may see smaller reductions in subjective HFs compared with normal-weight women and women in the early perimenopausal and postmenopausal stages. The reasons for this potentially differential response could not be discerned in this study, warranting further investigation. Objectively assessed overall physical activity was not associated with selfreported HFs across a 2-week period; however, performing more moderate-intensity PA on a given day was associated with higher reporting of HFs, especially among lower fit women. Cardiorespiratory fitness may represent an important individual difference variable that is modifiable, underscoring the importance of sustained PA participation in women undergoing the menopausal transition.
